Sigma Healthcare Share Price – Latest ASX Data and Insights
Sigma Healthcare Limited currently trades between $2.62 and $2.64 Australian dollars on the Australian Securities Exchange, representing narrow daily fluctuations of approximately 1.12 percent in either direction. The pharmaceutical distributor, operating under the ticker SIG, has experienced significant volatility throughout fiscal year 2025, though recent 2026 year-to-date performance shows a contraction exceeding ten percent from January opening levels.
Market data reveals substantial discrepancies across financial platforms regarding the company’s precise market capitalisation and current trading status, with conflicting reports on whether the stock maintains active quotation. These inconsistencies highlight the importance of verifying real-time data through official ASX channels when evaluating the stock’s current position.
What is the Current Sigma Healthcare Share Price?
The share price has demonstrated resilience despite recent declines, maintaining levels significantly above the fiscal year 2025 starting point of $1.265. Market Index data indicates the stock has outperformed the broader ASX 200 by approximately eleven percentage points over the trailing twelve-month period.
- Sigma Healthcare trades under the official ASX code SIG
- Year-to-date 2026 performance reflects a -10.20% decline from January opening prices
- Fiscal year 2025 delivered exceptional returns of +136.36%
- Daily trading volume consistently ranges between 15 and 25 million shares
- The 52-week price range extends from $1.205 to $3.32
- Data sources conflict regarding active trading status and precise market valuation
| Metric | Value | Notes |
|---|---|---|
| ASX Code | SIG | Healthcare sector |
| Current Price | $2.62–$2.64 | As of late March 2026 |
| 52-Week High | $3.32 | Reached in FY2025 |
| 52-Week Low | $1.205 | FY2025 trough |
| 2026 YTD Change | -10.20% | From $2.94 opening |
| FY2025 Change | +136.36% | Strong growth phase |
| Market Capitalisation | $4.5B–$30.6B | Conflicting reports |
| Revenue Growth | +104.9% | Annual average |
| Earnings Growth | +30.8% | Vs industry -23.6% |
| Return on Equity | 12.2% | As of Dec 2025 |
| Full-Time Employees | 156 | Company data |
| Fiscal Year End | 30 June | 2026 |
What is Sigma Healthcare’s ASX Code and Key Basics?
ASX Listing and Ticker Information
Sigma Healthcare Limited maintains its primary listing on the Australian Securities Exchange under the three-letter ticker symbol SIG. The company operates within the healthcare sector, specifically classified under medical distribution, and carries a defensive stock designation according to Morningstar classifications. The organisation functions as a full-line wholesale pharmaceutical distributor serving community pharmacy networks throughout Australia.
Corporate Fundamentals
The company employs 156 full-time staff and maintains a fiscal year ending 30 June. Recent financial filings indicate robust operational expansion, with annual revenue growth reaching 104.9 percent alongside a net profit margin of 6.3 percent. These metrics position the distributor favourably against the broader healthcare industry, which has experienced negative earnings growth of 23.6 percent during the same comparative period according to Simply Wall Street analysis.
Financial platforms report conflicting market capitalisation figures for Sigma Healthcare, ranging from 4.5 billion AUD to 30.6 billion AUD. This substantial variance suggests differences in calculation methodology or timing of data updates across providers.
Why is Sigma Healthcare Share Price Moving Recently?
Recent Corporate Announcements
The most recent price-sensitive announcement occurred on 25 February 2026, when the company released its half-year financial results to the market. This disclosure followed a period of significant volatility, with the ASX registering substantial volume spikes including a single-day turnover of 32.8 million shares on 31 March 2025. The February 2026 results represented the latest formal corporate communication available regarding financial performance.
Trading Activity Patterns
Daily trading volumes have moderated in early 2026 compared to the elevated activity witnessed throughout fiscal year 2025, averaging 15.2 million shares year-to-date versus 25.4 million shares last year. Some market analysis platforms suggest the stock may no longer trade actively, citing last recorded prices of $3.020, though this conflicts with continuous pricing updates from primary exchange sources. Investors monitoring Intelligent Investor data observe ongoing quote updates indicating maintained liquidity.
Research specifically seeking information regarding takeover bids, mergers with Chemist Warehouse, or analyst consensus ratings yielded no verifiable results. The ASX company page references analyst consensus availability, but specific recommendations or price targets remain undocumented in available public sources.
Sigma Healthcare Performance Metrics and History?
Historical Price Trajectory
The twelve-month performance chart reveals extraordinary volatility, with fiscal year 2025 delivering gains of 136.36 percent as shares climbed from $1.265 to $2.99. The 52-week high of $3.32 established during this period represents a significant premium to current trading levels around $2.64. However, fiscal year 2026 has reversed this trajectory, with shares declining 11.11 percent since the July opening price of $2.97.
Financial Growth Indicators
Underlying operational metrics support the long-term valuation expansion witnessed in 2025. The company maintains a 12.2 percent return on equity while sustaining annual earnings growth of 30.8 percent, substantially outpacing sector peers. Revenue expansion of 104.9 percent annually indicates successful scaling of distribution capabilities, though recent share price softening suggests market concerns regarding sustainability of these growth rates or broader sector headwinds affecting defensive healthcare positions.
Sigma Healthcare has outperformed the ASX 200 index by approximately 11 percentage points over the trailing twelve months, delivering +122.54 percent compared to the index’s +111.47 percent return.
One analysis platform indicates the stock is “no longer actively traded” with a last price of $3.020, down 2.27 percent. This contrasts with live pricing data showing continued quotation and volume, suggesting data feed variations rather than actual delisting.
How Has the Sigma Healthcare Share Price Changed Over Time?
- – Trading volume spikes to 32.8 million shares with daily range of $2.89–$2.93, closing at $2.88
- – Price trades within $2.80–$3.06 range as volatility continues following strong FY2025 opening
- – Full fiscal year delivers +136.36% return, climbing from $1.265 to $2.99 with highs reaching $3.32
- – Fiscal year 2026 commences at $2.94, with early trading reaching $3.20 before declining
- – Half-year results released to market as price-sensitive announcement
- – Shares trade down to $2.62, representing the 2026 low and approximately -10.20% year-to-date
What is Established and What Remains Uncertain?
Verified Information
- ASX ticker symbol SIG and healthcare sector classification
- Current trading price approximately $2.62–$2.64 AUD
- Historical performance data showing FY2025 growth of +136.36%
- Corporate fundamentals: 156 employees, FY end 30 June
- Revenue growth of 104.9% and ROE of 12.2%
- Half-year results announced 25 February 2026
Unresolved Questions
- Exact market capitalisation (conflicting reports: $4.5B vs $30.6B AUD)
- Current active trading status (some sources indicate inactive)
- Specific dividend amounts and payout history
- Analyst ratings or consensus price targets
- Status of potential Chemist Warehouse merger or takeover bids
- Enterprise value calculations and debt levels
What is the Broader Context for Sigma Healthcare?
Sigma Healthcare operates within the medical distribution sub-sector, functioning as a defensive stock typically sought during market uncertainty. The company’s role as a full-line wholesale pharmaceutical distributor positions it as essential infrastructure within Australia’s healthcare supply chain, serving community pharmacies with consistent demand characteristics regardless of economic cycles.
The stock’s remarkable 122.54 percent annual performance compares favourably against both the healthcare industry average and the broader ASX 200 index. This outperformance occurred despite sector headwinds that saw industry earnings decline by 23.6 percent annually, suggesting Sigma captured market share or benefited from specific distribution contracts that insulated it from broader pharmaceutical margin pressures.
Investors comparing defensive healthcare positions might examine Bubs Share Price for exposure to infant nutrition markets, or review operational cost benchmarks through services like Car Service Near Me when evaluating logistics-dependent distribution models similar to Sigma’s pharmaceutical wholesale operations.
What Do Official Sources Indicate?
Sigma Healthcare Limited operates as a full-line wholesale pharmaceutical distributor to community pharmacy, seeking to secure the future of pharmacy through industry influence and viable healthcare delivery.
— Australian Securities Exchange Company Information
The company reported a 52-week high of $3.32 and low of $1.205, with recent trading volume averaging 15.2 million shares daily in 2026 versus 25.4 million in 2025.
— Market Index Trading Data
What is the Key Takeaway for Sigma Healthcare Share Price?
Sigma Healthcare trades at approximately $2.62–$2.64 AUD, representing a significant premium to its fiscal year 2025 starting levels despite recent year-to-date declines of 10 percent. While operational metrics demonstrate exceptional revenue and earnings growth exceeding sector averages, prospective investors must navigate conflicting data regarding market capitalisation and trading status while acknowledging the absence of verifiable information regarding potential merger activity or analyst consensus targets. Those monitoring similar market segments may find comparative value in reviewing Bubs Share Price movements.
Frequently Asked Questions
How can investors verify the live Sigma Healthcare share price?
The most reliable source remains the official Australian Securities Exchange website, which provides real-time quotation data for ASX: SIG. Independent financial platforms like Market Index and Intelligent Investor also aggregate this data, though slight timing delays may occur.
What explains the conflicting market capitalisation figures for SIG?
Sources report figures ranging from 4.5 billion AUD to 30.6 billion AUD. This discrepancy likely stems from different calculation methodologies, timing of data updates, or potential confusion regarding enterprise value versus equity market cap.
Does Sigma Healthcare pay dividends to shareholders?
Available research does not specify particular dividend amounts or payout histories. The company’s recent announcements have focused on share plan implementations rather than dividend distributions. Investors should consult the latest ASX release for current income policies.
Is there a confirmed merger with Chemist Warehouse affecting the share price?
Research conducted across available sources found no verifiable information regarding Chemist Warehouse merger activity, takeover bids, or related corporate actions. ASX announcements do not currently document such transactions.
Why do some platforms show SIG as not actively trading?
One analysis source indicates inactive trading status with a stale price of $3.020. This contradicts primary exchange data showing continuous quotation and daily volume, suggesting a technical data feed issue rather than actual trading suspension.
What sector classification applies to Sigma Healthcare?
The company falls within the healthcare sector, specifically medical distribution. Morningstar classifies it as a defensive stock, typically indicating stable demand regardless of economic cycles.
How does SIG’s performance compare to the broader market?
Over twelve months, Sigma Healthcare returned 122.54 percent, outperforming the ASX 200 index which gained 111.47 percent during the same period according to available market data.
More related posts
22 Inches in CM: 55.88 cm for Clothing, Hair Extensions
Bank of Dave 2: The Loan Ranger – Is It Worth Watching?
American Civil War – Causes Timeline Battles Leaders
Pink Flamingo Gold Coast: Closure, Shows, and Venue Facts
Easy Airport Parking: Reviews, Rates & Booking Guide
Chadwick Boseman’s Wife: Simone Ledward Boseman’s Life & Legacy
Chris Hemsworth Movies – Full List and Best Films
James Ransone Dead at 46: The Wire Actor’s Life and Legacy
